InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
24
T+90 hit rate
38%
T+90 mean return
+13.6%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Ticho Barry, Directeur Médical. Director active across 1 company, notably Stoke Therapeutics, Inc.. Aggregated, 41 filings have been recorded. Split: 0 buy · 24 sells. Total volume traded: €2.8m. Activity tracked since 13 July 2021. The latest transaction was filed on 1 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations41 total
6,728 shares@ US$32.6150.011% mcap5.7% of flowCommon StockSEC:0001780088-26-000015:0
500 shares@ US$33.26780.0008% mcap0.4% of flowCommon StockSEC:0001780088-26-000015:1
1,838 shares@ US$32.661.5% of flowCommon StockSEC:0001780088-26-000009:0
3,577 shares@ US$32.73944.0% of flowCommon StockSEC:0001780088-26-000006:0
13,100 shares0Common StockSEC:0001780088-26-000004:0
10,000 shares0Common StockSEC:0001780088-25-000006:0
11,981 shares0Common StockSEC:0001780088-25-000005:0
3,776 shares@ US$25.22422.9% of flowCommon StockSEC:0001780088-25-000004:0
5,343 shares@ US$23.64143.8% of flowCommon StockSEC:0001780088-25-000003:0
5,501 shares@ US$19.87373.5% of flowCommon StockSEC:0001415889-25-023591:0
2,805 shares@ US$18.2381.7% of flowCommon StockSEC:0001415889-25-022442:0
10,000 shares0Common StockSEC:0001415889-25-022227:0
4,504 shares@ US$12.81622.0% of flowCommon StockSEC:0001415889-25-021024:0
4,503 shares@ US$11.63211.8% of flowCommon StockSEC:0001415889-25-019004:0
1,745 shares@ US$10.000.6% of flowCommon StockSEC:0001415889-25-015693:0
3,841 shares@ US$10.001.1% of flowCommon StockSEC:0001415889-25-011940:0
3,884 shares@ US$8.671.0% of flowCommon StockSEC:0001415889-25-008710:0
13,100 shares0Common StockSEC:0001415889-25-008359:0
2,586 shares@ US$12.99131.0% of flowCommon StockSEC:0001415889-24-028930:0
13,945 shares@ US$12.77755.3% of flowCommon StockSEC:0001415889-24-028892:0
10,000 shares0Common StockSEC:0001415889-24-028396:0
48,792 shares0Common StockSEC:0001415889-24-028069:0
10,000 shares@ US$0.600.2% of flowCommon StockSEC:0001415889-24-026135:0
10,000 shares@ US$0.600.2% of flowCommon StockSEC:0001415889-24-024378:0
10,000 shares@ US$0.600.2% of flowCommon StockSEC:0001415889-24-022900:0
25 of 41 declarations
About Ticho Barry
Barry Ticho is the Chief Medical Officer at Stoke Therapeutics, Inc. He oversees the medical and clinical aspects of the company, ensuring compliance and innovation. His medical expertise is essential for the development of the company's products.
